Viking Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Jan '25 Jan 23, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	3,081	1,461	598	266	301	438	Upgrade
Market Cap Growth	476.76%	144.27%	125.11%	-11.65%	-31.25%	2.02%	Upgrade
Enterprise Value	2,326	1,167	471	106	114	221	Upgrade
Last Close Price	27.69	14.66	7.50	3.40	4.61	5.44	Upgrade
PB Ratio	7.70	5.34	4.96	1.78	1.68	2.09	Upgrade
P/TBV Ratio	7.70	5.34	4.96	1.78	1.68	2.09	Upgrade
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.00	Upgrade
Quick Ratio	36.23	18.92	7.08	23.02	20.48	40.67	Upgrade
Current Ratio	36.47	19.19	7.61	23.98	21.12	41.83	Upgrade
Return on Equity (ROE)	-15.50%	-34.79%	-39.67%	-24.65%	-15.15%	-8.97%	Upgrade
Return on Assets (ROA)	-12.68%	-23.47%	-23.19%	-14.90%	-9.86%	-6.97%	Upgrade
Return on Capital (ROIC)	-13.06%	-25.38%	-25.21%	-15.58%	-10.21%	-7.10%	Upgrade
Earnings Yield	-2.40%	-4.61%	-9.55%	-15.28%	-9.62%	-4.45%	Upgrade
FCF Yield	-1.06%	-3.94%	-6.71%	-13.22%	-5.30%	-4.27%	Upgrade
Buyback Yield / Dilution	-19.97%	-22.79%	0.47%	-6.34%	-0.89%	-24.97%	Upgrade
Total Shareholder Return	-19.97%	-22.79%	0.47%	-6.34%	-0.89%	-24.97%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.